Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-09 Sale | 2022-02-11 6:07 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 2,971 | $36.3 | $107,847 | 334,970 (Direct) | View |
| 2021-02-09 Sale | 2021-02-11 8:28 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 60,000 | $137.48 | $8,249,038 | 681,213 (Direct) | View |
| 2020-05-21 Purchase | 2020-05-26 5:55 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 4,166 | $60 | $249,960 | 26,872 (Direct) | View |
| 2020-03-24 Purchase | 2020-03-25 8:26 pm | Passage BIO Inc. | PASG | Countouriotis Athena Director | 10,000 | $14.97 | $149,750 | 18,900 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:37 pm | Passage BIO Inc. | PASG | Countouriotis Athena Director | 8,900 | $18 | $160,200 | 8,900 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-11 Option Award | 2024-06-13 6:03 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director | 49,303 | $0 | 49,303 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:43 pm | N/A 2034-05-21 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 47,693 | $0 | 47,693 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 5:14 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Countouriotis Athena Director | 4,720 | $0 | 6,900 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 5:50 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-12-27 Option Award | 2023-12-28 1:03 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | Countouriotis Athena Director | 2,180 | $0 | 2,180 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:22 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director | 51,955 | $0 | 51,955 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-26 4:22 pm | N/A 2033-05-24 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:23 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 110,959 | $76 | 0 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-17 4:23 pm | N/A 2028-06-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 2,038,194 | $0 | 0 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 5:03 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director | 51,204 | $0 | 51,204 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 4:20 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:07 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 287,040 | $0 | 334,970 (Direct) | View |
| 2021-06-29 Option Award | 2021-07-01 4:17 pm | N/A 2031-06-29 | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 5:50 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 16,918 | $0 | 16,918 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A 2028-06-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 60,000 | $0 | 681,213 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 60,000 | $3.2 | 681,213 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:52 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 124,392 | $0 | 151,970 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 8:00 pm | N/A 2030-06-07 | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Countouriotis Athena Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 6:05 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 33,836 | $0 | 33,836 (Direct) | View |
| 2019-12-10 Option Award | 2020-01-08 4:24 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 706 | $31.13 | 347,706 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:24 pm | N/A 2030-01-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 325,000 | $0 | 347,706 (Direct) | View |